| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 13 |
| 1 | LISINOPRIL | 13 |
| 2 | VALSARTAN | 13 |
| 3 | PANTOPRAZOLE | 12 |
| 4 | VALSARTAN ORAL | 12 |
| 5 | NIFEDIPINE | 11 |
| 6 | RAMIPRIL | 11 |
| 7 | RIVAROXABAN | 10 |
| 8 | LEVOTHYROXINE SODIUM | 9 |
| 9 | LEVOTHYROXINE SODIUM ANHYDROUS | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 1 | AMINOCAPROIC ACID | 3 | 0.0037 |
| 2 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 3 | 0.0027 |
| 3 | PSYLLIUM HUSK | 1 | 0.0007 |
| 4 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 5 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 6 | 0.0007 |
| 6 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 2 | 0.0005 |
| 7 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 8 | COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN | 1 | 0.0004 |
| 9 | EMICIZUMAB | 5 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 18 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 |
| 2 | Calcium Channel Blocker [EPC] | 13 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 11 |
| 4 | Factor Xa Inhibitor [EPC] | 10 |
| 5 | Benzodiazepine [EPC] | 8 |
| 6 | Proton Pump Inhibitor [EPC] | 8 |
| 7 | Corticosteroid [EPC] | 5 |
| 8 | Estrogen [EPC] | 5 |
| 9 | Progesterone [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 2 | Progesterone [EPC] | 5 | 0.0002 |
| 3 | Bismuth [EPC] | 1 | 0.0002 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 11 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 9 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |